Scarica l'app Stockscreener
2.70
1.50%
0.04
Dopo l'orario di chiusura:
2.69
-0.01
-0.37%
Precedente Chiudi:
$2.66
Aprire:
$2.68
Volume 24 ore:
699.50K
Relative Volume:
1.70
Capitalizzazione di mercato:
$232.20M
Reddito:
$25.14M
Utile/perdita netta:
$-21.57M
Rapporto P/E:
-10.00
EPS:
-0.27
Flusso di cassa netto:
$-12.23M
1 W Prestazione:
+20.00%
1M Prestazione:
+20.00%
6M Prestazione:
+18.94%
1 anno Prestazione:
+34.33%
Intervallo 1D:
$2.6138
$2.71
Intervallo di 1 settimana:
$2.18
$2.71
Portata 52W:
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
Nome
Stereotaxis Inc
Settore
Industria
Telefono
314-678-6100
Indirizzo
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Confronta STXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.70 | 229.24M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
482.34 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.48 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-10 | Iniziato | ROTH MKM | Buy |
| 2022-07-12 | Iniziato | Aegis Capital | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2022-01-05 | Iniziato | Craig Hallum | Buy |
| 2022-01-05 | Iniziato | Loop Capital | Buy |
| 2021-05-26 | Iniziato | Piper Sandler | Overweight |
| 2020-09-08 | Iniziato | Northland Capital | Outperform |
| 2020-04-09 | Iniziato | Cowen | Outperform |
| 2020-04-07 | Iniziato | Lake Street | Buy |
Mostra tutto
Stereotaxis Inc Borsa (STXS) Ultime notizie
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates - MSN
Stereotaxis, Inc. (AMEX:STXS) Q2 2025 Earnings Call Transcript - Insider Monkey
Stereotaxis: Pioneering the Future of Robotic Cardiology Amid Strategic Momentum - AInvest
Is Stereotaxis Inc. stock a hidden gemWealth Funnel Stock Screener - newsyoung.net
Does Stereotaxis Inc. show high probability of reboundFree Weekly Watchlist of High Movers - Newser
Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum - MSN
Forecasting Stereotaxis Inc. price range with options dataFree Day Trading Signals With High Precision - Newser
Intraday pattern recognizer results for Stereotaxis Inc.Strong Buy Signal Summary with Entry Zone - Newser
Historical volatility pattern of Stereotaxis Inc. visualizedFree Daily Smart Money Movement Monitor - Newser
Regression analysis insights on Stereotaxis Inc. performanceFree Triple Digit Growth Focused Trade Plan - Newser
What makes Stereotaxis Inc. stock price move sharplyBuy and Hold Position Summary Review - Newser
Should I buy Stereotaxis Inc. stock before earningsFree Weekly Setup With 3x Return Potential - Newser
Stereotaxis Reports Double-Digit Revenue Growth for 2025 Amidst New Catheter Launches - AInvest
Stereotaxis (STXS): A Robotics-Driven Inflection Point in 2025 - AInvest
Is Stereotaxis Inc. a Top Dividend Stock to Watch in 2025Buy Candidate Summary Based on Fundamentals - Newser
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts - Investing.com
Best data tools to analyze Stereotaxis Inc. stockFree Weekly Hot Picks With Buy Confidence - Newser
Stereotaxis Inc. recovery potential after sell offLow Risk Trade Timing with Analysis Metrics - Newser
Stereotaxis Q2 2025 Earnings: Revenue Surges to $8.8 Million, EPS of -$0.05 Beats Estimates. - AInvest
Stereotaxis Inc (STXS) Q2 2025 Earnings Call Highlights: Impressive Revenue Surge and Strategic Advancements - GuruFocus
Transcript : Stereotaxis, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Stereotaxis reports Q2 EPS (5c), consensus (6c) - TipRanks
Stereotaxis earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Unlocking Value in Stereotaxis: A High-Growth Medical Tech Play in a Resilient Sector - AInvest
Stereotaxis Reports 2025 Second Quarter Financial Results - GlobeNewswire
Stereotaxis Reports Massive 95% Revenue Jump as New FDA-Cleared Robotic Catheter Drives Growth - Stock Titan
Will Stereotaxis Inc. see short term momentumAI Generated Momentum Stock Forecast Guide - Newser
Does Stereotaxis Inc. stock perform well during market downturnsUnbelievable profit margins - Jammu Links News
What drives Stereotaxis Inc. stock pricePhenomenal returns - Jammu Links News
How strong is Stereotaxis Inc. company’s balance sheetAccelerated investment success - Jammu Links News
What are analysts’ price targets for Stereotaxis Inc. in the next 12 monthsUnprecedented profit potential - Jammu Links News
Should I hold or sell Stereotaxis Inc. stock in 2025Maximize returns with disciplined trading - Jammu Links News
How does Stereotaxis Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Stereotaxis Inc. Stock Analysis and ForecastDynamic profit expansion - Jammu Links News
What is Stereotaxis Inc. company’s growth strategyRapidly growing investment returns - Jammu Links News
Is Stereotaxis Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
What institutional investors are buying Stereotaxis Inc. stockFree Buy/Sell Signal Notifications - Jammu Links News
Trendlines Suggest Stereotaxis Inc. May Bottom Out SoonAccurate Buy Point for Momentum Stocks Detected - metal.it
Stereotaxis Inc.’s volatility index tracking explainedFree Reliable Alerts for Daily Stock Movers - Newser
What are Stereotaxis Inc. company’s key revenue driversAI Powered Growth Plan For 2025 - Jammu Links News
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared - MedTech Dive
Stereotaxis Inc. Q2 Earnings Preview: Revenue Up 76.7%, EPS Unchanged - AInvest
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Is Stereotaxis Inc. stock bottoming outReliable Alerts for Daily Stock Movers Released - metal.it
Why did STXS revenue surge in Q3 2024 despite rising expenses? - AInvest
How does Stereotaxis Inc. generate profit in a changing economySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Navigating STXS’s Stock Market Maze: Ups and Downs in 2025 - investchronicle.com
Stereotaxis' MAGiC Sweep: A Strategic Inflection Point in Robotic Electrophysiology - AInvest
Stereotaxis wins FDA clearance for diagnostic mapping catheter - Yahoo Finance
Stereotaxis' FDA-Cleared MAGiC Sweep Catheter: A Catalyst for Growth in the Robotic Ablation Era - AInvest
Stereotaxis Inc Azioni (STXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):